Literature DB >> 20029803

No evidence of porcine endogenous retrovirus in patients with type 1 diabetes after long-term porcine islet xenotransplantation.

Rafael Valdes-Gonzalez1, Luis M Dorantes, Eduardo Bracho-Blanchet, Ana Rodríguez-Ventura, D J G White.   

Abstract

Xenotransplantation is a promising alternative for donor shortage to ameliorate physiologic and metabolic disorders. The major concern for xenotransplant is the risk of zoonosis mainly by the porcine endogenous retrovirus (PERV), presentation in the piglet genome. Twenty-three patients with type 1 diabetes were transplanted with porcine islets using collagen-generating devices which were implanted subcutaneously in the anterior wall of the abdomen. Clinical characteristics and metabolic tests were recorded in each visit. They were tested for PERV using PCR and RT-PCR from blood pretransplantation and every 3 months during a 4.6- to 8-year follow-up after their first xenotransplant. Tests by PCR of every DNA sample (780 samples) revealed that there was no PERV infection in the DNA of white cells. No evidence of PERV activation was found in this group of patients with type 1 diabetes during clinical long-term follow-up. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20029803     DOI: 10.1002/jmv.21655

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  19 in total

1.  Long-term follow-up of patients with type 1 diabetes transplanted with neonatal pig islets.

Authors:  R Valdes-Gonzalez; A L Rodriguez-Ventura; D J G White; E Bracho-Blanchet; A Castillo; B Ramírez-González; M G López-Santos; B H León-Mancilla; L M Dorantes
Journal:  Clin Exp Immunol       Date:  2010-10-21       Impact factor: 4.330

2.  Analysis of a retrospective double-centre data-collection for the treatment of burns using biological cover Xe-derma®.

Authors:  H Klosová; L Klein; J Bláha
Journal:  Ann Burns Fire Disasters       Date:  2014-12-31

Review 3.  Pig-to-Primate Islet Xenotransplantation: Past, Present, and Future.

Authors:  Zhengzhao Liu; Wenbao Hu; Tian He; Yifan Dai; Hidetaka Hara; Rita Bottino; David K C Cooper; Zhiming Cai; Lisha Mou
Journal:  Cell Transplant       Date:  2017-02-03       Impact factor: 4.064

Review 4.  Islet transplantation and encapsulation: an update on recent developments.

Authors:  Vijayaganapathy Vaithilingam; Bernard E Tuch
Journal:  Rev Diabet Stud       Date:  2011-05-10

5.  Long-term safety from transmission of porcine endogenous retrovirus after pig-to-non-human primate corneal transplantation.

Authors:  Hyuk Jin Choi; Jiyeon Kim; Jae Young Kim; Hyun Ju Lee; Won Ryang Wee; Mee Kum Kim; Eung Soo Hwang
Journal:  Xenotransplantation       Date:  2017-05-14       Impact factor: 3.907

Review 6.  Optimal pig donor selection in islet xenotransplantation: current status and future perspectives.

Authors:  Hai-tao Zhu; Liang Yu; Yi Lyu; Bo Wang
Journal:  J Zhejiang Univ Sci B       Date:  2014-08       Impact factor: 3.066

Review 7.  Porcine Islet Xenografts: a Clinical Source of ß-Cell Grafts.

Authors:  Bassem F Salama; Gregory S Korbutt
Journal:  Curr Diab Rep       Date:  2017-03       Impact factor: 4.810

8.  Screening pigs for xenotransplantation: expression of porcine endogenous retroviruses in transgenic pig skin.

Authors:  Magdalena Kimsa-Dudek; Barbara Strzalka-Mrozik; Malgorzata W Kimsa; Irena Blecharz; Joanna Gola; Bartlomiej Skowronek; Adrian Janiszewski; Daniel Lipinski; Joanna Zeyland; Marlena Szalata; Ryszard Slomski; Urszula Mazurek
Journal:  Transgenic Res       Date:  2015-03-27       Impact factor: 2.788

9.  Identification and promoter analysis of PERV LTR subtypes in NIH-miniature pig.

Authors:  Yi-Deun Jung; Hong-Seok Ha; Sang-Je Park; Keon-Bong Oh; Gi-Sun Im; Tae-Hun Kim; Hwan-Hoo Seong; Heui-Soo Kim
Journal:  Mol Cells       Date:  2013-02-21       Impact factor: 5.034

Review 10.  Ethical considerations in tissue engineering research: Case studies in translation.

Authors:  Hannah B Baker; John P McQuilling; Nancy M P King
Journal:  Methods       Date:  2015-08-14       Impact factor: 3.608

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.